Enterotoxin
| Stap_Strp_tox_C | |||||||||
|---|---|---|---|---|---|---|---|---|---|
 identification of a secondary zinc-binding site in staphylococcal enterotoxin c2: implications for superantigen recognition | |||||||||
| Identifiers | |||||||||
| Symbol | Stap_Strp_tox_C | ||||||||
| Pfam | PF02876 | ||||||||
| Pfam clan | CL0386 | ||||||||
| InterPro | IPR006123 | ||||||||
| PROSITE | PDOC00250 | ||||||||
| SCOP2 | 1se3 / SCOPe / SUPFAM | ||||||||
| OPM superfamily | 364 | ||||||||
| OPM protein | 1dyq | ||||||||
| |||||||||
An enterotoxin is a protein exotoxin released by a microorganism that targets the intestines.[1]
Enterotoxins are chromosomally encoded or plasmid encoded[2] exotoxins that are produced and secreted from several bacterial organisms. They are often heat-stable, and are of low molecular weight and water-soluble. Enterotoxins are frequently cytotoxic and kill cells by altering the apical membrane permeability of the mucosal (epithelial) cells of the intestinal wall. They are mostly pore-forming toxins (mostly chloride pores), secreted by bacteria, that assemble to form pores in cell membranes. This causes the cells to die.
Clinical significance
Enterotoxins have a particularly marked effect upon the gastrointestinal tract, causing traveler's diarrhea and food poisoning. The action of enterotoxins leads to increased chloride ion permeability of the apical membrane of intestinal mucosal cells. These membrane pores are activated either by increased cAMP or by increased calcium ion concentration intracellularly. The pore formation has a direct effect on the osmolarity of the luminal contents of the intestines. Increased chloride permeability leads to leakage into the lumen followed by sodium and water movement. This leads to a secretory diarrhea within a few hours of ingesting enterotoxin. Several microbial organisms contain the necessary enterotoxin to create such an effect, such as Staphylococcus aureus and E. coli.[3]
The drug linaclotide, used to treat some forms of constipation, is based on the mechanism of enterotoxins.[3]
Classification and 3D structures
Bacterial
Enterotoxins can be formed by the bacterial pathogens Staphylococcus aureus and Bacillus cereus and can cause Staphylococcal Food Poisoning and Bacillus cereus diarrheal disease, respectively. Staphylococcal enterotoxins and streptococcal exotoxins constitute a family of biologically and structurally related pyrogenic superantigens[4]. Staphylococcal enterotoxins are mainly produced by Staphylococcus aureus. However, it has been suggested that staphylococci other than S. aureus can contribute to Staphylococcal Food Poisoning by forming enterotoxins[5]. Streptococcal exotoxins are produced by Streptococcus pyogenes.[6][7] These toxins share the ability to bind to the major histocompatibility complex proteins of their hosts. A more distant relative of the family is the S. aureus toxic shock syndrome toxin, which shares only a low level of sequence similarity with this group.
All of these toxins share a similar two-domain fold (N and C-terminal domains) with a long alpha-helix in the middle of the molecule, a characteristic beta-barrel known as the "oligosaccharide/oligonucleotide fold" at the N-terminal domain and a beta-grasp motif at the C-terminal domain. Examples include staphylococcal enterotoxin B. Each superantigen possesses slightly different binding mode(s) when it interacts with MHC class II molecules or the T-cell receptor.[8]
The beta-grasp domain has some structural similarities to the beta-grasp motif present in immunoglobulin-binding domains, ubiquitin, 2Fe-2 S ferredoxin and translation initiation factor 3 as identified by the SCOP database.
- Clostridium difficile
- Clostridium perfringens (Clostridium enterotoxin)[9]
- Vibrio cholerae (Cholera toxin)[10]
- Staphylococcus aureus (Staphylococcal enterotoxin B)[11]
- Yersinia enterocolitica
- Shigella dysenteriae (Shiga toxin)[10]
Viral
See also
References
- ^ "enterotoxin" at Dorland's Medical Dictionary
- ^ Carlton Gyles, Magdalene So, Stanley Falkow, Journal of Infectious Diseases (1974) 130 (1): 40-49.
- ^ a b Hornby, PJ (2015). "Drug discovery approaches to irritable bowel syndrome". Expert opinion on drug discovery. 10 (8): 809–24. doi:10.1517/17460441.2015.1049528. PMID 26193876.
- ^ Dinges, M. M.; Orwin, P. M.; Schlievert, P. M. (2000). "Exotoxins of Staphylococcus aureus". Clinical Microbiology Reviews. 13 (1): 16–34, table of contents. ISSN 0893-8512. PMID 10627489.
- ^ Fetsch, Alexandra; Johler, Sophia (2018-04-27). "Staphylococcus aureus as a Foodborne Pathogen". Current Clinical Microbiology Reports. 5 (2): 88–96. doi:10.1007/s40588-018-0094-x. ISSN 2196-5471.
- ^ Iandolo JJ (1989). "Genetic analysis of extracellular toxins of Staphylococcus aureus". Annu. Rev. Microbiol. 43: 375–402. doi:10.1146/annurev.mi.43.100189.002111. PMID 2679358.
- ^ Marrack P, Kappler J (May 1990). "The staphylococcal enterotoxins and their relatives". Science. 248 (4956): 705–11. doi:10.1126/science.2185544. PMID 2185544.
- ^ Papageorgiou AC, Tranter HS, Acharya KR (March 1998). "Crystal structure of microbial superantigen staphylococcal enterotoxin B at 1.5 A resolution: implications for superantigen recognition by MHC class II molecules and T-cell receptors". J. Mol. Biol. 277 (1): 61–79. doi:10.1006/jmbi.1997.1577. PMID 9514739.
- ^ Katahira J, Sugiyama H, Inoue N, Horiguchi Y, Matsuda M, Sugimoto N (October 1997). "Clostridium perfringens enterotoxin utilizes two structurally related membrane proteins as functional receptors in vivo". The Journal of Biological Chemistry. 272 (42): 26652–8. doi:10.1074/jbc.272.42.26652. PMID 9334247.
{{cite journal}}: CS1 maint: unflagged free DOI (link) - ^ a b Enterotoxins at the U.S. National Library of Medicine Medical Subject Headings (MeSH)
- ^ "eMedicine - CBRNE - Staphylococcal Enterotoxin B : Article by Danielle M Pesce". Retrieved 2008-11-08.
External links
- Alfonse T. Masi; Rafael A. Timothee; Rolando Armijo; Darwin Alonso; Luis E. Mainardi (Mar 1959). "Two poisoning outbreaks in Puerto Rico from salt preserved codfish". Public Health Rep. 74 (3): 265–270. doi:10.2307/4590423. PMC 1929208. PMID 13634314.
